Your browser doesn't support javascript.
loading
Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2.
Chu, Xiaoyu; Ding, Xinyu; Yang, Yixuan; Lu, Yuchi; Li, Tinghan; Gao, Yan; Zheng, Le; Xiao, Hang; Yang, Tingting; Cheng, Hao; Huang, Haibin; Liu, Yang; Lou, Yang; Wu, Chao; Chen, Yuxin; Yang, Haitao; Ji, Xiaoyun; Guo, Hangtian.
Affiliation
  • Chu X; The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, 210023, China.
  • Ding X; Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, 210008, China; School of Environmental and Biological Engineering, Nanjing University of Science & Technology, Nanjing, Jiangsu, 210094, China.
  • Yang Y; The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, 210023, China.
  • Lu Y; Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
  • Li T; The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, 210023, China.
  • Gao Y; Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China; Shanghai Clinical Research and Trial Center, Shanghai, 201210, China.
  • Zheng L; The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, 210023, China.
  • Xiao H; Yurogen Biosystem LLC, Wuhan, Hubei, 430075, China.
  • Yang T; The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, 210023, China.
  • Cheng H; Yurogen Biosystem LLC, Wuhan, Hubei, 430075, China.
  • Huang H; Yurogen Biosystem LLC, Wuhan, Hubei, 430075, China.
  • Liu Y; Yurogen Biosystem LLC, Wuhan, Hubei, 430075, China.
  • Lou Y; Yurogen Biosystem LLC, Wuhan, Hubei, 430075, China.
  • Wu C; Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu, 210008, China.
  • Chen Y; Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, 210008, China; Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu, 210008, China. Electronic address: yuxin.chen@nju.edu.cn.
  • Yang H; Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China; Shanghai Clinical Research and Trial Center, Shanghai, 201210, China.
  • Ji X; The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, 210023, China; Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu, 210008, China. Electronic address: xiaoyun.ji@nju.edu.cn.
  • Guo H; The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, 210023, China. Electronic address: guohangtian@nju.edu.cn.
Biochem Biophys Res Commun ; 660: 43-49, 2023 06 11.
Article in En | MEDLINE | ID: mdl-37062240
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Biochem Biophys Res Commun Year: 2023 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Biochem Biophys Res Commun Year: 2023 Type: Article Affiliation country: China